Evaluating the combination of molecular prognostic factors in tumor radiosensitivity in rectal cancer

Hepato-Gastroenterology

Volumn 52, Issue 63, 2005, Pages 666-671

  Komuro, Yasuhiro ^a   Watanabe, Toshiaki ^a   Tsurita, Giichiro ^a   Muto, Tetsuichiro ^b   Nagawa, Hirokazu ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b CANCER INSTITUTE HOSPITAL   (Japan)

Author keywords

Immunohistochemistry; Ku; p16; p21; p53; Preoperative radiotherapy; Rectal carcinoma

Indexed keywords

KU ANTIGEN; KU86 PROTEIN; PROTEIN P16; PROTEIN P21; PROTEIN P53; UNCLASSIFIED DRUG;

ADULT; ADVANCED CANCER; AGED; ARTICLE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MOLECULAR BIOLOGY; PREDICTION; PREOPERATIVE RADIOTHERAPY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RADIOSENSITIVITY; RECTUM BIOPSY; RECTUM CANCER;

ADULT; AGED; CELL SURVIVAL; COMBINED MODALITY THERAPY; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DNA HELICASES; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RECTAL NEOPLASMS; RECTUM; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 20644446078     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Eu KW, Seow-Choen F, Ho JM, Ho YH, Leong AF: Local recurrence following rectal resection for cancer. J R Coll Surg Edinb 1998; 43:393-396.
2. Harris GJ, Church JM, Senagore AJ, Lavery IC, Hull TL, Strong SA, Fazio VW: Factors affecting local recurrence of colonic adenocarcinoma. Dis Colon Rectum 2002; 45:1029-1034.
3. Fisher B, Wolmark N, Rockette H, Redmond C, Deutsch M, Wickerham DL, Fisher ER, Caplan R, Jones J, Lerner H: Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP protocol R-01. J Natl Cancer Inst 1988; 80:21-29.
4. Kennedy HL, Langevin JM, Goldberg SM, Nivatvongs S, Balcos EG, Christenson CE, Nemer FD, Rothenberger DA, Schottler JL: Recurrence following stapled coloproctostomy for carcinomas of the mid portion of the rectum. Surg Gynecol Obstet 1985; 160:513-516.
5. Gerard A, Buyse M, Nordlinger B, Loygue J, Pene F, Kempf P, Bosset JF, Gignoux M, Arnaud JP, Desaive C: Preoperative radiotherapy as adjuvant treatment in rectal cancer. Final results of a randomized study of the European Organization for Research and Treatment of Cancer (EORTC). Ann Surg 1988; 208:606-614.
6. Colombo PL, Foglieni CL, Morone C: Analysis of recurrence following curative low anterior resection and stapled anastomoses for carcinoma of the middle third and lower rectum. Dis Colon Rectum 1987; 30:457-464.
7. Sause WT, Pajak TF, Noyes RD, Dobelbower R, Fischbach J, Doggett S, Mohiuddin M: Evaluation of preoperative radiation therapy in operable colorectal cancer. Ann Surg 1994; 220:668-675.
8. Holm T, Cedermark B, Rutqvist LE: Local recurrence of rectal adenocarcinoma after 'curative' surgery with and without preoperative radiotherapy. Br J Surg 1994; 81:452-455.
9. Marsh PJ, James RD, Schofield PF: Adjuvant preoperative radiotherapy for locally advanced rectal carcinoma. Results of a prospective, randomized trial. Dis Colon Rectum 1994; 37:1205-1214.
10. Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer Trial. N Engl J Med 1997; 336:980-987.
11. Dahlberg M, Glimelius B, Pahlman L: Improved survival and reduction in local failure rates after preoperative radiotherapy: evidence for the generalizability of the results of Swedish Rectal Cancer Trial. Ann Surg 1999; 229:493-497.
12. Komuro Y, Watanabe T, Hosoi Y, Matsumoto Y, Nakagawa K, Saito S, Ishihara S, Kazama S, Tsuno N, Kitayama J, Suzuki N, Nagawa H: Prediction of tumor radiosensitivity in rectal carcinoma based on p53 and Ku70 expression. J Exp Clin Cancer Res 2003; 22:223-228.
13. Furuta K, Konishi F, Kanazawa K, Saito K, Sugawara T: Synergistic effects of hyperthermia in preoperative radiochemotherapy for rectal carcinoma. Dis Colon Rectum 1997; 40:1303-1312.
14. Bouzourene H, Bosman FT, Seelentag W, Matter M, Coucke P: Importance of tumor regression assessment in predicting the outcome in patients with locally advanced rectal carcinoma who are treated with preoperative radiotherapy. Cancer 2002; 94:1121-1130.
15. Saw RP, Morgan M, Koorey D, Painter D, Findlay M, Stevens G, Clarke S, Chapuis P, Solomon MJ: p53, deleted in colorectal cancer gene, and thymidylate synthase as predictors of histopathologic response and survival in low, locally advanced rectal cancer treated with preoperative adjuvant therapy. Dis Colon Rectum 2003; 46:192-202.
16. Komuro Y, Watanabe T, Hosoi Y, Matsumoto Y, Nakagawa K, Tsuno N, Kazama S, Kitayama J, Suzuki N, Nagawa H: The expression pattern of Ku correlates with tumor radiosensitivity and disease free survival in patients with rectal carcinoma. Cancer 2002; 95:1199-1205.
17. Levine AJ: p53, the cellular gatekeeper for growth and division. Cell 1997; 88:323-331.
18. McIlwrath AJ: Cell cycle arrests and radiosensitivity of human tumor cell lines: dependence on wild-type p53 for radiosensitivity. Cancer Res 1994; 54:3718-3722.
19. Hamada M: The p53 gene is a potent determinant of chemosensitivity and radiosensitivity in gastric and colorectal cancers. J Cancer Res Clin Oncol 1996; 122:360-365.
20. Ko LJ: p53: puzzle and paradigm. Genes Dev 1996; 10:1054-1072.
21. Raybaud-Diogene H: Markers of radioresistance in squamous cell carcinomas of the head and neck: a clinicopathologic and immunohistochemical study. J Clin Oncol 1997; 15:1030-1038.
22. Desai GR: Carcinoma of the rectum. Possible cellular predictors of metastatic potential and response to radiation therapy. Dis Colon Rectum 1996; 39:1090-1096.
23. Servomaa K: p53 mutations associated with increased sensitivity to ionizing radiation in human head and neck cancer cell lines. Cell Prolif 1996; 29:219-230.
24. Fu CG, Tominaga O, Nagawa H, Nita ME, Masaki T, Ishimaru G, Higuchi Y, Tsuruo T, Muto T: Role of p53 and p21/WAF1 detection in patient selection for preoperative radiotherapy in rectal cancer patients. Dis Colon Rectum 1998; 41:68-74.
25. Matsumoto Y, Suzuki N, Namba N, Umeda N, Ma XJ, Morita A, Tomita M, Enomoto A, Serizawa S, Hirano K, Sakaia K, Yasuda H, Hosoi Y: Cleavage and phosphorylation of XRCC4 protein induced by X-irradiation. FEBS Lett 2000; 478:67-71.
26. Darwish H, Trejo IE, Shapira I, Oweineh S, Sughayer M, Baron L, Aljadeff E, Silbermann M, Sweidan W, Zilberg D, Halpern Z, Hibshoosh H, Arber N: Fighting colorectal cancer: molecular epidemiology differences among Ashkenazi and Sephardic Jews and Palestinians. Ann Oncol 2002; 13:1497-1501.
27. Korshunov A, Golanov A: The prognostic significance of DNA topoisomerase II-alpha (Ki-S1), p21/Cip-1, and p27/ Kip-1 protein immunoexpression in oligodendrogliomas. Arch Pathol Lab Med 2001; 125:892-898.
28. Cheng L, Lloyd RV, Weaver AL, Pisansky TM, Cheville JC, Ramnani DM, Leibovich BC, Blute ML, Zincke H, Bostwick DG: The cell cycle inhibitors p21WAF1 and p27KIP1 are associated with survival in patients treated by salvage prostatectomy after radiation therapy. Clin Cancer Res 2000; 6:1896-1899.
29. Japanese Research Society for Cancer of the Colon and Rectum: Criteria for histopathological evaluation of radiotherapy effect. In: General rules for clinical and pathological studies on cancer of the colon, rectum and anus. 6th Edition. Tokyo: Kanehara & Co., 1998.
30. Ross GM: Induction of cell death by radiotherapy. Endocr Relat Cancer 1999; 6:41-44.
31. Wilson CR, Davidson SE, Margison GP, Jackson SP, Hendry JH, West CM: Expression of Ku70 correlates with survival in carcinoma of the cervix. Br J Cancer 2000; 83:1702-1706.
32. Lowe SW, Bodis S, McClatchey A, Remington L, Ruley HE, Fisher DE, Housman DE, Jacks T: p53 status and the efficacy of cancer therapy in vivo. Science 1994; 266:807-810.
33. Miyashita T, Reed JC: Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line. Blood 1993; 81:151-157.
34. Lane DP: Mutation of the p53 gene and accumulation of the p53 protein: Common steps found in the majority of human cancers. In: Fortner JG, Rhodes JE (Eds.). Accomplishments in Cancer Research. Philadelphia: J.B. Lippincott, 1990; pp. 252-266.